Racemetirosinum
Racemetirosinum Uses, Dosage, Side Effects, Food Interaction and all others data.
Racemetirosinum is under investigation in clinical trial NCT03512756 (A Randomized Phase 2/3 Multi-center Study of SM-88 in Patients With Metastatic Pancreatic Cancer).
| Trade Name | Racemetirosinum |
| Generic | Racemetyrosine |
| Racemetyrosine Other Names | AMPT, DL-metyrosine, Racemetirosina, Racemetirosine, Racemetirosinum, Racemetyrosine |
| Type | |
| Formula | C10H13NO3 |
| Weight | Average: 195.218 Monoisotopic: 195.089543283 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Racemetirosinum
